Linsitinib is a potent, selective insulin-like growth factor-1 receptor (IGF-1R, IC50 = 35 nM) and insulin receptor (IR, IC50 = 75 nM) kinase inhibitor which works to block the autophosphorylation of IGF-1R and IR. Additionally, in vitro studies of
Linsitinib is a potent, selective insulin-like growth factor-1 receptor (IGF-1R, IC50 = 35 nM) and insulin receptor (IR, IC50 = 75 nM) kinase inhibitor which works to block the autophosphorylation of IGF-1R and IR. Additionally, in vitro studies of
Linsitinib is a potent, selective insulin-like growth factor-1 receptor (IGF-1R, IC50 = 35 nM) and insulin receptor (IR, IC50 = 75 nM) kinase inhibitor which works to block the autophosphorylation of IGF-1R and IR. Additionally, in vitro studies of
Linsitinib is a potent, selective insulin-like growth factor-1 receptor (IGF-1R, IC50 = 35 nM) and insulin receptor (IR, IC50 = 75 nM) kinase inhibitor which works to block the autophosphorylation of IGF-1R and IR. Additionally, in vitro studies of
The choice of coating material is based on the stationary phase of the GC. Coated GC packing is done by coating a 6% carbowax -20M liquid phase on a chromosorb support.
The choice of coating material is based on the stationary phase of the GC. Coated GC packing is done by coating a 6% carbowax -20M liquid phase on a chromosorb support.
This certified reference material (CRM) is produced and certified in accordance with ISO/IEC 17025. This CRM is traceable to primary material from an NMI, e.
This certified reference material (CRM) is produced and certified in accordance with ISO/IEC 17025. This CRM is traceable to primary material from an NMI, e.
Application Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.
Application Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.